Lakshmi Harinath
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lakshmi Harinath has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Amy Colaizzi
Department of Pathology, UPMC Magee Womens Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania
7 shared publicationsEsther Elishaev
Department of Pathology, UPMC Magee Womens Hospital University of Pittsburgh Pittsburgh Pennsylvania USA
6 shared publicationsRohit Bhargava
Department of Pathology, UPMC Magee Womens Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania
6 shared publicationsChengquan Zhao
Department of Pathology, UPMC Magee Womens Hospital University of Pittsburgh Pittsburgh Pennsylvania USA
5 shared publications- Chengquan Zhao
Department of Pathology, University of Pittsburgh Medical Center , Pittsburgh, PA
5 shared publications Jonee Matsko
Department of Pathology, UPMC Magee Womens Hospital University of Pittsburgh Pittsburgh Pennsylvania USA
5 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by Wiley in Cytopathology
Unique Presentation of Metastatic Malignant Germ Cell Tumour Diagnosed on Pleural Effusion Cytology
- 22 July 2026
- Published by Wiley in Cytopathology
Open AccessUnique Presentation of Metastatic Malignant Germ Cell Tumour Diagnosed on Pleural Effusion Cytology
- 19 June 2026
- Published by Wiley in Diagnostic Cytopathology
- Vol. 54 (9)
Cytologic Detection of Metastatic Immature Teratomas in Two Young Patients With Unique Presentations
Ovarian immature teratomas are rare malignant germ cell tumors composed of immature embryonal tissues, most commonly neuroepithelium, and account for less than 1% of all ovarian teratomas. Cytologic diagnosis is challenging because of overlapping morphologic features with other high‐grade malignant neoplasms and the limited utility of immunohistochemistry. Herein, we report two cases of high‐grade ovarian immature teratomas with metastatic immature neuroepithelial components in young women of childbearing age, emphasizing the cytologic findings, immunophenotypic features, histologic grading, and clinical course.
- 19 June 2026
- Published by Wiley in Diagnostic Cytopathology
- Vol. 54 (9)
Cytologic Detection of Metastatic Immature Teratomas in Two Young Patients With Unique Presentations
Ovarian immature teratomas are rare malignant germ cell tumors composed of immature embryonal tissues, most commonly neuroepithelium, and account for less than 1% of all ovarian teratomas. Cytologic diagnosis is challenging because of overlapping morphologic features with other high‐grade malignant neoplasms and the limited utility of immunohistochemistry. Herein, we report two cases of high‐grade ovarian immature teratomas with metastatic immature neuroepithelial components in young women of childbearing age, emphasizing the cytologic findings, immunophenotypic features, histologic grading, and clinical course.
- 25 April 2026
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 15 (5) , 369-377
Determination of an optimal quality control method for Pap test analysis using digital cytology and artificial intelligence
- 25 April 2026
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 15 (5) , 369-377
Determination of an optimal quality control method for Pap test analysis using digital cytology and artificial intelligence
- 4 December 2025
- Published by Wiley in Diagnostic Cytopathology
- Vol. 54 (3) , 173-183
Morphologic Evaluation of Hyperchromatic Crowded Groups Present in Cervical Thin Prep Cytology Tests as Identified by the Hologic Genius Digital Diagnostics System: A Descriptive Study
Background: Our descriptive study focused on morphologic characteristics of hyperchromatic crowded groups (HCGs) in ThinPrep cervical cytology tests when reviewed with the artificial intelligence (AI)‐assisted Hologic Genius Digital Diagnostics System (HGDDS). Method: After IRB approval, our archives were searched over a 1‐year period for potential HCGs. A total of 157 slides with HCGs were selected, scanned, and analyzed using the HGDDS. One cytologist and one cytopathologist interpreted these cases while enumerating the cytomorphologic characteristics as seen with the HGDDS. Results: Of the 157 cases, a total of 84.7% were called Negative for Intraepithelial Lesion or Malignancy (NILM) on original ThinPrep interpretation (OTPI) as opposed to 76.4% with HGDDS. 5.7% and 3.2% of the cases were called high‐grade squamous intraepithelial lesion (HSIL) and atypical glandular cells (AGC) on OTPI, as compared to 4.5% and 8.3% on HGDDS. 6.4% of cases were interpreted as adenocarcinoma on both OTPI and HGDDS. A total of 16 cases were called NILM‐Atrophy by both modalities. Concordance for pathologist diagnosis between HGDDS and OTPI for 157 cases was 0.610 (kappa value). For 25 cases, there was a follow‐up biopsy diagnosis, including 10 cases of adenocarcinoma, 5 of Cervical Intraepithelial Neoplasia (CIN) 2–3, and 1 case of CIN 1. The sensitivity, specificity, positive predictive value, and negative predictive value for the detection of CIN2+ lesions, when ASC‐H/AGC and above were considered, were 100%, 50%, 75%, and 100%, respectively. Conclusion: Our initial study shows encouraging results in the evaluation of HCGs presented as two‐dimensional static images on a computer monitor by the HGDDS.
- 4 December 2025
- Published by Wiley in Diagnostic Cytopathology
- Vol. 54 (3) , 173-183
Morphologic Evaluation of Hyperchromatic Crowded Groups Present in Cervical Thin Prep Cytology Tests as Identified by the Hologic Genius Digital Diagnostics System: A Descriptive Study
Background: Our descriptive study focused on morphologic characteristics of hyperchromatic crowded groups (HCGs) in ThinPrep cervical cytology tests when reviewed with the artificial intelligence (AI)‐assisted Hologic Genius Digital Diagnostics System (HGDDS). Method: After IRB approval, our archives were searched over a 1‐year period for potential HCGs. A total of 157 slides with HCGs were selected, scanned, and analyzed using the HGDDS. One cytologist and one cytopathologist interpreted these cases while enumerating the cytomorphologic characteristics as seen with the HGDDS. Results: Of the 157 cases, a total of 84.7% were called Negative for Intraepithelial Lesion or Malignancy (NILM) on original ThinPrep interpretation (OTPI) as opposed to 76.4% with HGDDS. 5.7% and 3.2% of the cases were called high‐grade squamous intraepithelial lesion (HSIL) and atypical glandular cells (AGC) on OTPI, as compared to 4.5% and 8.3% on HGDDS. 6.4% of cases were interpreted as adenocarcinoma on both OTPI and HGDDS. A total of 16 cases were called NILM‐Atrophy by both modalities. Concordance for pathologist diagnosis between HGDDS and OTPI for 157 cases was 0.610 (kappa value). For 25 cases, there was a follow‐up biopsy diagnosis, including 10 cases of adenocarcinoma, 5 of Cervical Intraepithelial Neoplasia (CIN) 2–3, and 1 case of CIN 1. The sensitivity, specificity, positive predictive value, and negative predictive value for the detection of CIN2+ lesions, when ASC‐H/AGC and above were considered, were 100%, 50%, 75%, and 100%, respectively. Conclusion: Our initial study shows encouraging results in the evaluation of HCGs presented as two‐dimensional static images on a computer monitor by the HGDDS.
- Open Access
- 20 November 2025
- Published by Elsevier in Journal of Pathology Informatics
- Vol. 20
Technical considerations during validation of the Genius® Digital Diagnostic System
- 20 November 2025
- Published by Elsevier in Journal of Pathology Informatics
- Vol. 20
Open AccessTechnical considerations during validation of the Genius® Digital Diagnostic System
- 8 July 2025
- Published by S. Karger AG in Acta Cytologica
- Vol. 70 (1) , 52-71
Artificial Intelligence in Gynecologic Cytology
Background: Cervical cancer is the fourth most common cancer in women globally with highest incidence and mortality identified in less developed and medically underserved areas in the world. The diminishing cytology workforce, unavailability of expert consultation, and the high volume of Pap tests needing manual screening are the main reasons for exploring innovative solutions to help mitigate the negative effects resulting from the dearth of timely cervical cancer screening in certain population groups. Summary: Developments in whole slide imaging and artificial intelligence (AI) have enabled the emergence of new computer-assisted systems that have the potential for transforming traditional cytopathology practice. However, AI-based systems are relatively new with limited published data on their validation and clinical utility in clinical practice. Our article aims to increase awareness of the availability of such systems, explores the history and development of AI-assisted screening platforms for Pap tests, compares the performance characteristics of various systems, elaborates on technical challenges associated with conducting clinical trials employing this technology, and discusses considerations around deploying such systems in routine cytopathology practice. Key Message: Revolutionary AI-based systems are being developed and utilized in cytopathology practice to screen Pap tests. Some of these systems have good performance characteristics and provide opportunities to combat various issues such as workload and standardization faced by cytology laboratories globally. However, judicious review of these systems using evidence-based studies is imperative to promote widespread adoption and maintain high-quality standards for patient safety.
- 8 July 2025
- Published by S. Karger AG in Acta Cytologica
- Vol. 70 (1) , 52-71
Artificial Intelligence in Gynecologic Cytology
Background: Cervical cancer is the fourth most common cancer in women globally with highest incidence and mortality identified in less developed and medically underserved areas in the world. The diminishing cytology workforce, unavailability of expert consultation, and the high volume of Pap tests needing manual screening are the main reasons for exploring innovative solutions to help mitigate the negative effects resulting from the dearth of timely cervical cancer screening in certain population groups. Summary: Developments in whole slide imaging and artificial intelligence (AI) have enabled the emergence of new computer-assisted systems that have the potential for transforming traditional cytopathology practice. However, AI-based systems are relatively new with limited published data on their validation and clinical utility in clinical practice. Our article aims to increase awareness of the availability of such systems, explores the history and development of AI-assisted screening platforms for Pap tests, compares the performance characteristics of various systems, elaborates on technical challenges associated with conducting clinical trials employing this technology, and discusses considerations around deploying such systems in routine cytopathology practice. Key Message: Revolutionary AI-based systems are being developed and utilized in cytopathology practice to screen Pap tests. Some of these systems have good performance characteristics and provide opportunities to combat various issues such as workload and standardization faced by cytology laboratories globally. However, judicious review of these systems using evidence-based studies is imperative to promote widespread adoption and maintain high-quality standards for patient safety.
- Open Access
- 21 June 2025
- Published by Wiley in Cancer Cytopathology
- Vol. 133 (7) , e70022
Assessment of the efficacy and accuracy of cervical cytology screening with the Hologic Genius Digital Diagnostics System
Background: Medical technologies powered by artificial intelligence are quickly transforming into practical solutions by rapidly leveraging massive amounts of data processed via deep learning algorithms. There is a necessity to validate these innovative tools when integrated into clinical practice.Methods: This study evaluated the performance of the Hologic Genius Digital Diagnostics System (HGDDS) with a cohort of 890 previously reviewed and diagnosed ThinPrep Papanicolaou (Pap) tests with the intent to deploy this system for routine clinical use. The study included all diagnostic categories of The Bethesda System, with follow‐up tissue sampling performed within 6 months of abnormal Pap test results to serve as the ground truth.Results: The HGDDS demonstrated excellent performance in detecting significant Pap test findings, with close to 100% sensitivity (98.2%–100%) for cases classified as atypical squamous cells of undetermined significance and above within a 95% confidence interval and a high negative predictive value (92.4%–100%).Conclusions: The HGDDS streamlined workflow, reduced manual workload, and functioned as a stand‐alone system.
- 21 June 2025
- Published by Wiley in Cancer Cytopathology
- Vol. 133 (7) , e70022
Open AccessAssessment of the efficacy and accuracy of cervical cytology screening with the Hologic Genius Digital Diagnostics System
Background: Medical technologies powered by artificial intelligence are quickly transforming into practical solutions by rapidly leveraging massive amounts of data processed via deep learning algorithms. There is a necessity to validate these innovative tools when integrated into clinical practice.Methods: This study evaluated the performance of the Hologic Genius Digital Diagnostics System (HGDDS) with a cohort of 890 previously reviewed and diagnosed ThinPrep Papanicolaou (Pap) tests with the intent to deploy this system for routine clinical use. The study included all diagnostic categories of The Bethesda System, with follow‐up tissue sampling performed within 6 months of abnormal Pap test results to serve as the ground truth.Results: The HGDDS demonstrated excellent performance in detecting significant Pap test findings, with close to 100% sensitivity (98.2%–100%) for cases classified as atypical squamous cells of undetermined significance and above within a 95% confidence interval and a high negative predictive value (92.4%–100%).Conclusions: The HGDDS streamlined workflow, reduced manual workload, and functioned as a stand‐alone system.
- 6 June 2025
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 14 (5) , 347-357
Assessment of reprocessed ThinPrep cytology cases after glacial acetic acid wash procedure using the Hologic Genius Digital Diagnostics System
- 6 June 2025
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 14 (5) , 347-357
Assessment of reprocessed ThinPrep cytology cases after glacial acetic acid wash procedure using the Hologic Genius Digital Diagnostics System
- 18 January 2025
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 14 (3) , 199-207
Diagnostic performance of the hologic genius digital diagnostics system for low-grade squamous intraepithelial lesion (LSIL) ThinPrep papanicolaou tests
- 18 January 2025
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 14 (3) , 199-207
Diagnostic performance of the hologic genius digital diagnostics system for low-grade squamous intraepithelial lesion (LSIL) ThinPrep papanicolaou tests